ANGO - AngioDynamics Inc logo

AngioDynamics Inc

ANGO

AngioDynamics designs, manufactures, and sells medical devices for treating peripheral vascular disease and oncology, including atherectomy systems, thrombus management tools, and ablation systems, serving healthcare providers in the U.S. and internationally.

โš•๏ธ Healthcare NASDAQ Listed 2004 $ USD
$1,000 invested 20 years ago โ†’$540today

Score Overview

1 Year
Score
Net Growth10.36%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth1.63%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.9
Net Growth-24.07%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth2.90%
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-367.04%
Net Trend60%
Net Income Consistency
Rev Growth-6.94%
Rev Trend60%
Revenue Consistency
20 Years
Score3.2
Net Growth-260.86%
Net Trend55%
Net Income Consistency
Rev Growth189.93%
Rev Trend65%
Revenue Consistency
All Time
Score
Net Growth-10x
Net Trend57%
Net Income Consistency
Rev Growth6x
Rev Trend70%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where AngioDynamics Inc has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • ANGO

2015: 52.3% ยท 2021: 96.3% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-11-17
$ 11.49โ€”
1 Year2025-11-17
$ 11.91-3.53%
5 Years2021-11-17
$ 29.51-61.06%
10 Years2016-11-17
$ 16.78-31.53%
20 Years2006-11-17
$ 21.28-46.01%
All Time2004-05-27
$ 12.50-8.08%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 325M-$ 32M$ 33M
2026$ 320M-$ 36M$ 53M
2025$ 292M-$ 33M$ 55M
2024$ 303M-$ 184M$ 76M
2023$ 338M-$ 52M$ 44M
2022$ 316M-$ 26M$ 28M
2021$ 291M-$ 31M$ 48M
2020$ 264M-$ 166M$ 54M
2019$ 359M$ 61M$ 227M
2018$ 344M$ 16M$ 75M
2017$ 349M-$ 7M$ 48M
2016$ 353M-$ 43M$ 33M
2015$ 356M-$ 3M$ 20M
2014$ 354M$ 2M$ 17M
2013$ 342M-$ 1M$ 23M
2012$ 221M-$ 5M$ 37M
2011$ 215M$ 8M$ 131M
2010$ 216M$ 12M$ 100M
2009$ 195M$ 9M$ 68M
2008$ 166M$ 10M$ 78M
2007$ 112M-$ 9M$ 71M
2006$ 78M$ 6M$ 89M
2005$ 60M$ 4M$ 27M
IPO2004$ 49M$ 3M$ 2M
ANGO - AngioDynamics Inc logo

AngioDynamics Inc fundamental performance

Between 2021 and 2026, revenue grew from $ 291M to $ 320M and net income went from -$ 31M to -$ 36M. Revenue increased in 3 of those 5 years; net income in 2.

Across AngioDynamics Inc's full reported history, from 2004 to 2026, revenue grew from $ 49M to $ 320M and net income went from $ 3M to -$ 36M. Revenue increased in 70% of the years measured; net income in 57%.

AngioDynamics Inc currently holds a 20-year HDB Score of 3.2 out of 10. How the HDB Score is calculated.

Membership

Continue ANGOโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,187 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$149 / year

or $19/month

Continue with Membership

30-day money-back guarantee.

Explore other companies